An IgA anti-transglutaminase 2 (TGA-IgA) antibody cut-off of approximately 6.1 times the upper limit of normal optimised celiac disease diagnosis in children and adolescents with type 1 diabetes ...
A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...
By Rayk Riechmann As one of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to improve the ...
A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.
7d
News-Medical.Net on MSNGut microbiota impacts pneumococcal vaccine response in immunodeficient individualsGut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.
Most people recover from norovirus, a highly contagious infection, within a few days but it can be particularly risky for ...
Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause ...
those with MS had a smaller number of bacteria coated in an antibody known as host immunoglobulin A (IgA). These antibodies are pumped into the gut by immune cells that live in the mucosa—the ...
A new vaccine pill trial is currently underway to treat the highly contagious norovirus infection, which has led to a record ...
In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it ...
Vaxart (VXRT) announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results